UBS Group
MDCXW

UBS Group’s Medicus Pharma Warrant MDCXW Stock Holding History

UBS Group’s Portfolio MDCXW Stock Details MDCXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$820 Buy
+1,465
New +$1.2K ﹤0.01% 9725
2025
Q2 		– Sell
-2,299
Closed -$1.61K – 11061
2025
Q1 		$1.61K Buy
2,299
+299
+15% +$310 ﹤0.01% 9477
2024
Q4 		$702 Buy
+2,000
New +$1.28K ﹤0.01% 9397

Other funds holding MDCXW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

UBS Group's MDCXW Position: Q1 2026 in Review

UBS Group opened a new position in Medicus Pharma Warrant (MDCXW) in Q1 2026: 1,465 shares worth $820. The stake represents ﹤0.01% of the portfolio and ranks #9725 among its holdings. This is a return to the name: UBS Group previously reported a position in MDCXW as recently as Q1 2025.

UBS Group first reported a position in MDCXW in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.61K in Q1 2025. 6 funds tracked by Wall St. Rank hold MDCXW as of Q1 2026.

  • UBS Group held 1,465 shares of Medicus Pharma Warrant worth $820 as of Q1 2026.
  • Medicus Pharma Warrant was a new UBS Group position in Q1 2026.
  • Medicus Pharma Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9725 holding.
  • UBS Group first reported a position in Medicus Pharma Warrant in Q4 2024 and has held it in 3 quarters since.
  • UBS Group's Medicus Pharma Warrant position peaked at $1.61K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.